Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Income towards Parent Company (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Income towards Parent Company for 6 consecutive years, with -$44.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 559.03% year-over-year to -$44.1 million, compared with a TTM value of -$66.5 million through Dec 2025, down 1005.3%, and an annual FY2025 reading of -$66.5 million, down 1005.3% over the prior year.
  • Income towards Parent Company was -$44.1 million for Q4 2025 at Cytek Biosciences, down from -$5.5 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $9.6 million in Q4 2024 and bottomed at -$44.1 million in Q4 2025.
  • Average Income towards Parent Company over 5 years is -$4.0 million, with a median of -$1.7 million recorded in 2021.
  • Peak annual rise in Income towards Parent Company hit 419.14% in 2022, while the deepest fall reached 2215.69% in 2022.
  • Year by year, Income towards Parent Company stood at -$1.2 million in 2021, then soared by 419.14% to $3.7 million in 2022, then skyrocketed by 48.01% to $5.5 million in 2023, then surged by 74.49% to $9.6 million in 2024, then crashed by 559.03% to -$44.1 million in 2025.
  • Business Quant data shows Income towards Parent Company for CTKB at -$44.1 million in Q4 2025, -$5.5 million in Q3 2025, and -$5.6 million in Q2 2025.